Article citationsMore>>
Winter, Y.M., Balzer-Geldsetzer, A., Spottke, J.P., Reese, E., Baum, J., Klotsche, J., Rieke, A., Simonow, K., Eggert, W.H., Oertel and Dodel, R. (2010) Longitudinal study of the socioeconomic burden of Parkinson’s disease in Germany. European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies, 17, 1156-1163.
has been cited by the following article:
-
TITLE:
Can population genomics guide future therapeutic gene transfer strategies for Parkinson’s disease?
AUTHORS:
Massimo S. Fiandaca, Robert M. Padilla, Ishmeal Conteh, Howard J. Federoff
KEYWORDS:
Biomarkers; Functional Imaging; Gene Therapy; Parkinson’s Disease; Population Genomics; Prodromal Phase
JOURNAL NAME:
Open Journal of Genetics,
Vol.3 No.2A,
June
26,
2013
ABSTRACT:
Medical and surgical therapies for patients with Parkinson’s disease (PD)
are typically considered and initiated upon development of clinical signs, especially
therapeutic gene transfer therapies. Early clinical trials delivering transgenes
within the brains of PD patients have confirmed their safety and suggested mild
to moderate efficacy. Confirmatory phase III trials have yet to be undertaken
with any of the current treatment regimens. During the development of PD gene
therapy, mapping of the human genome was finalized and provides major insights
into the normal and pathogenic genetic variabilities of populations. Genome
wide association studies (GWAS) have expanded the genetic defects and risk
factors accompanying clinical PD. Advanced genomic investigations may allow
asymptomatic individuals with a high risk of developing PD, and evident
presymptomatic nigrostriatal deficiencies, to consider early treatment
approaches. Herein we propose that certain genomically and clinically defined
PD patients may provide unique opportunities for testing neuronotrophic gene
therapy in a pathobiological environment that is antecedent to overt motoric
dysfunction. Such an approach may finally allow testing of the disease-altering
capabilities of therapeutic gene transfer in PD.
Related Articles:
-
Nazila Zarghi, Seyed Reza Mazlom, Majid Rahban
-
Allois Ruben, Beratto Luca, Ponzano Matteo, Di Leonardo Piergiacomo, Abate Daga Federico, Gollin Massimiliano
-
Robert McInnis, William Cavanaugh, Janice Weinberg, Marie-Hélène Saint-Hilaire, Samuel Ellias, Samuel Frank, Anna DePold Hohler
-
Manuel Galiñanes
-
Paola Bazán-Rodríguez, Eduardo Ichikawa-Escamilla, Etienne Reséndiz-Henríquez, Carlos E. Martínez-Cortés, Amin Cervantes-Arriaga, Mayela Rodríguez-Violante, Lisette Bazán-Rodríguez